Community, Long-Term Care Pharmacists Seek More Transparency From PBMs

Community and long-term care pharmacists are pressing for more transparency in pharmacy benefit managers' Maximum Allowable Cost lists that determine how much pharmacies are paid for generic drugs, pushing back against PBMs' claims that transparency could lead to higher drug prices. The press comes as lawmakers question whether the right economic incentives are in place for PBMs to keep drug prices as low as possible. The two sides faced off at a House hearing Tuesday (Nov. 17), where PBMs said...